Buy Indoco Remedies, target price Rs 430: Yes Securities

Buy Indoco Remedies, target price Rs 430: Yes Securities
ETMarkets.com
Share
Font Size
Save
Comment
Synopsis

Indoco Remedies Ltd., incorporated in the year 1947, is a Small Cap company (having a market cap of Rs 3654.22 Crore) operating in Pharmaceuticals sector.

ThinkStock Photos
A series of ascending tops and bottoms along with a sustained move above important averages is likely to keep the near-term outlook positive.

Related

Yes Securities has buy call on with a target price of Rs 430. The current market price of Indoco Remedies Ltd. is Rs 397.15. Time period given by analyst is Intra Day when Indoco Remedies price can reach defined target.

Indoco Remedies Ltd., incorporated in the year 1947, is a Small Cap company (having a market cap of Rs 3654.22 Crore) operating in Pharmaceuticals sector.

Financials
For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 307.12 Crore, down -7.67 % from last quarter Total Income of Rs 332.65 Crore and up 12.71 % from last year same quarter Total Income of Rs 272.49 Crore. Company reported net profit after tax of Rs 25.00 Crore in latest quarter.

Did you Know?

Stock score of Indoco Remedies Ltd moved up by 2 in a week.

View Latest Stock Report  »

Investment Rationale
A series of ascending tops and bottoms along with a sustained move above important averages is likely to keep the near-term outlook positive.

(Views and recommendations given in this section are the analysts' own and do not represent those of ETMarkets.com. Please consult your financial adviser before taking any position in the stock/s mentioned.)

Read More News on

(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

ETPrime stories of the day

Read before you invest. Insights on Indoco Remedies Ltd.. Explore Now